METHOD OF TREATING SPINAL ISCHEMIA IN EXPERIMENT Russian patent published in 2013 - IPC A61K38/18 A61P9/10 A61N5/67 

FIELD: medicine.

SUBSTANCE: invention refers to experimental medicine and may be used to treat simulated spinal ischemia in a biological object. The method involves three intraperitoneal administrations of human recombinant erythropoietin in 4-6, 24 and 48 hours after the action caused spinal ischemia. The amount of human recombinant erythropoietin per an injection is 5000 IU/kg. In 30-60 minutes after the first dose of human recombinant erythropoietin has been administered, a region in a projection of a spinal ischemia centre increased by 1-2 cm from the end above the affected region is exposed to diffuse percutaneous irradiation. The patient is exposed to infrared light generated by a diode laser at wave length 890 nm, power 2 Wt. The exposure is performed in the continuous mode for 3 minutes at 3-4 cm from the body surface of the biological object within the exposure area with the light guide movable at 5 mm/sec. The light guide moves along the exposure area spirally.

EFFECT: method provides the high clinical effectiveness in spinal ischemia in experiment.